Chesapeake Urology Executive and Leadership Team

Sanford Siegel, the Chief Executive Officer at Chesapeake Urology, directs the overarching strategic vision and operational framework for the organization. Siegel's leadership guides the expansion and integration of medical offices and surgery centers throughout Maryland and the Mid-Atlantic region. This executive function involves aligning corporate objectives with clinical excellence, ensuring the delivery of high-quality urological care across all facilities. Sanford Siegel oversees the strategic planning necessary to maintain Chesapeake Urology's position as a leading provider within the United Urology Group network. The focus remains on sustainable growth and enhancing patient access to specialized urological services. This role is critical in navigating the evolving healthcare landscape and driving innovation in patient treatment protocols.

Robert Jackson, the Market Chief Executive Officer at Chesapeake Urology, spearheads operational execution and market development across the Mid-Atlantic region. Jackson's responsibilities encompass optimizing the performance of numerous medical offices and surgery centers, ensuring seamless integration of services and patient care pathways. This leadership position drives regional growth initiatives and strengthens Chesapeake Urology's presence within its key markets. Robert Jackson focuses on enhancing operational efficiencies and fostering strong relationships with healthcare providers and communities. The market-focused strategy ensures localized needs are met while adhering to the broader organizational goals of United Urology Group. Jackson's oversight is crucial for maintaining high standards of service delivery and patient satisfaction throughout the operational territories.

Brad Lerner, the President at Chesapeake Urology, drives organizational development and strategic partnerships to enhance the company's market position. Lerner's leadership focuses on expanding the network of medical offices and surgery centers, ensuring robust operational capabilities and service integration. This executive role is critical in fostering growth and innovation within the United Urology Group framework. Brad Lerner oversees key initiatives aimed at improving patient access and the overall patient experience across the Mid-Atlantic region. The President's responsibilities include cultivating relationships with stakeholders and ensuring the organization's strategic objectives are met efficiently. Lerner's influence is pivotal in shaping the future direction and operational success of Chesapeake Urology.

Geoffrey Sklar, the Chief Medical Officer at Chesapeake Urology, directs clinical strategy and ensures the highest standards of patient care across all facilities. Sklar's purview includes overseeing medical protocols, quality assurance, and the implementation of advanced urological treatments. This executive function is vital for maintaining clinical excellence and fostering innovation in patient services throughout Maryland and the Mid-Atlantic. Geoffrey Sklar collaborates closely with physicians and clinical staff to enhance treatment outcomes and patient safety. The Chief Medical Officer's role is central to aligning clinical operations with the organization's mission of providing exceptional urological care. Sklar's leadership ensures that Chesapeake Urology remains at the forefront of medical advancements and patient-centered healthcare delivery.